MRVI vs XENE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

MRVI

42.4
AI Score
VS
XENE Wins

XENE

52.3
AI Score

Investment Advisor Scores

MRVI

42score
Recommendation
HOLD

XENE

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MRVI XENE Winner
Revenue 117.28M 264,000 MRVI
Net Income -16.15M -22.64M MRVI
Net Margin -13.8% -8575.4% MRVI
Operating Income -17.25M -24.52M MRVI
ROE -7.9% -52.3% MRVI
ROA -2.7% -48.8% MRVI
Total Assets 603.75M 46.36M MRVI
Cash 70.09M 14.69M MRVI
Free Cash Flow 7.85M -22.14M MRVI

Relative Price Performance (Last 90 Days)

MRVI 1M: +13.0% · 3M: +25.3% XENE 1M: -10.1% · 3M: +12.4%

Current Technical Phase

MRVI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.7 · Price: $6.53

XENE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 38

RSI (14): 38.5 · Price: $58.65

Fundamentals Snapshot

Metric MRVI XENE
Market Cap
Forward P/E -65.0 -12.2
Trailing P/E
Revenue (TTM)
Revenue Growth 0.1% -1.0%
Gross Margin 0.4%
Operating Margin -0.3% 0.0%
EPS -0.52 -4.73
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, XENE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.